LivaNova PLC has launched SenTiva DUO™, a new implantable pulse generator with a dual-pin header for VNS Therapy™ procedures. This recent IPG differs from the original SenTiva™, which is only available in a single-pin configuration with a dual-pin header. Patients who were first implanted with a dual-pin lead and IPG can now benefit from SenTiva DUO™, which marks the newest advancements in VNS Therapy technology.
SenTiva™ and SenTiva DUO™ both enable Day-Night Programming, Scheduled Programming, and can track rapid heart rate increases, low heart rates, and prone position events, which may be related to seizures.
We’re proud to offer SenTiva DUO to serve patients who were early adopters of VNS Therapy many years ago," said Damien McDonald, Chief Executive Officer of LivaNova. "Over time, all VNS Therapy patients must replace their generators as batteries become depleted. Now, our ‘pioneer patients’ will be able to take advantage of the latest technology with SenTiva DUO and experience the full benefits of VNS Therapy, without the need to replace their dual-pin lead."
Implantable Pulse Trackers
LivaNova Debuts the SenTiva DUO™ Implantable Pulse Generator
Trend Themes
1. Implantable Pulse Generators - The development of dual-pin headers for implantable pulse generators creates opportunities for improved patient care and expanded IPG usage.
2. Day-night Programming - The ability of IPGs to enable day-night programming creates opportunities for personalized patient care.
3. Remote Monitoring - Implantable pulse trackers that can track heart rates and prone position events create opportunities for remote patient monitoring and streamlined healthcare delivery.
Industry Implications
1. Medical Devices - The implantable pulse tracker industry is poised for growth as more advanced technology is developed and new patients seek VNS therapy.
2. Healthcare - The healthcare industry can take advantage of implantable pulse trackers by using day-night programming and remote patient monitoring to improve outcomes and reduce costs.
3. Technology - The development of new implantable pulse trackers and their associated technologies represents opportunity for innovation in the tech industry.